Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Tembhare

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Cancer Medicine|November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in IndiaSumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Indian Journal of Cancer|August 28, 2018
Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional auditNavin Khattry, Siddhartha Laskar, Manju Sengar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2025
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in IndiaSmeeta Gajendra, Tanima Dwivedi, Karthik Bommannan, et al.
Blood Cancer Journal|April 24, 2025
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib studyGaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, et al.
Blood Cancer Journal|May 20, 2025
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib studyGaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, et al.
Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsJoseph D Khoury, Eric Solary, Oussama Abla, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Cancer Medicine|November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in IndiaSumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Indian Journal of Cancer|August 28, 2018
Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional auditNavin Khattry, Siddhartha Laskar, Manju Sengar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2025
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in IndiaSmeeta Gajendra, Tanima Dwivedi, Karthik Bommannan, et al.
Blood Cancer Journal|April 24, 2025
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib studyGaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, et al.
Blood Cancer Journal|May 20, 2025
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib studyGaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, et al.
Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsJoseph D Khoury, Eric Solary, Oussama Abla, et al.
Pageof 9